Collaboration to develop and market vision analysis system

Article

Visiometrics and Medeuronet have formed together to develop and market Visiometrics' Optical Quality Analysis System (OQAS).

Visiometrics and Medeuronet have formed together to develop and market Visiometrics' Optical Quality Analysis System (OQAS).

Pan-European strategic commercial partner Medeuronet will market the system, created by Barcelona-based ophthalmic firm Visiometrics. OQAS is based on the works of Dr Pablo Artal, University of Murcia, Spain.

The system is based on the double-pass technique in which the punctual light source's size and shape projected onto the retina is analysed. The analysis will then provide the user with the point spread function (PSF), tear film quality, optical scattering index (OSI) and the modulation transfer function (MTF) of the eye.

Medeuronet aims to educate users on using the system in a clinical environment and how to make use of its benefits. The OQAS can be used to diagnose pathologies and compare pre and post-cataract and refractive surgery measurements and outcomes.

Other features of the OQAS include accommodation on retinal image quality, objective measurement of halos and glare and presenting the impact of higher-order aberrations and light scatter on visual acuity.

Visiometrics' Chief Executive Officer said, "We see this partnership with Medeuronet as a critical next step in the acceptance of OQAS on a wider commercial scale. We know that OQAS is the key tool to accurately and objectively assess the patient's quality of vision."

Related Videos
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Related Content
© 2023 MJH Life Sciences

All rights reserved.